Ultrafiltration versus IV Diuretics for Patients Hospitalized for Acute decompensated Congestive Heart Failure: A Prospective Randomized Clinical Trial

1
(No Transcript)
2
Investigators Sites
3
Background
4
Study Hypotheses
5
Primary End Points
6
Secondary End Points
7
MethodsInclusion Criteria
8
MethodsExclusion Criteria
9
MethodsStudy Procedures
10
MethodsStudy Procedures
11
MethodsUltrafiltration Device
12
MethodsStatistical Analysis
13
Baseline Demographics and Comorbidities
14
Baseline Heart Failure Characteristics
15
Baseline Functional Capacity and Vital Signs
16
Baseline Laboratory Values
17
Baseline Medications
18
(No Transcript)
19
Primary End PointWeight Loss at 48 Hr
Primary End PointWeight Loss at 48 Hr
20
Primary End PointDyspnea Score at 48 Hr
21
Secondary End PointNet Fluid Loss at 48 Hr
22
Worsening Heart Failure in 90 days
23
Freedom From Re-hospitalization for Heart Failure
24
Secondary End Points
25
Safety End Points Change in Serum Creatinine
26
Adverse events up to 90 days
27
Deaths up to 90 days
28
Safety End Points
29
Vasoactive Drugs Requirement
30
Summary
31
Conclusions